Nivolumab in children and young adults with relapsed or...

  • Main
  • 2020 / 3
  • Nivolumab in children and young adults with relapsed or...
The Lancet Oncology 2020 / 3

Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial

Davis, Kara L, Fox, Elizabeth, Merchant, Melinda S, Reid, Joel M, Kudgus, Rachel A, Liu, Xiaowei, Minard, Charles G, Voss, Stephan, Berg, Stacey L, Weigel, Brenda J, Mackall, Crystal L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(20)30023-1
Date:
March, 2020
File:
PDF, 498 KB
english, 2020
Conversion to is in progress
Conversion to is failed